Blackstone Inc. Makes New Investment in Inhibikase Therapeutics, Inc. (NYSE:IKT)
MarketBeat
Blackstone Inc. purchased a new stake in shares of Inhibikase Therapeutics, Inc. (NYSE:IKT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 2,070,684 shares of the company's stock, valued at approximately $
NYSE:IKT